Natco Pharma Ltd Nine Monthly Results

Gross Sales

3,208.5

2,930.5

1,809.2

1,348

1,720.8

Excise Duty

0

0

0

0

0

Net Sales

3,208.5

2,930.5

1,809.2

1,348

1,720.8

Other Operating Income

0

0

0

0

0

Other Income

288.2

86.1

75.6

85.2

75.2

Total Income

3,496.7

3,016.6

1,884.8

1,433.2

1,796

Total Expenditure

1,560.6

1,676.4

1,212.7

1,065.9

1,190.8

PBIDT

1,936.1

1,340.2

672.1

367.3

605.2

Interest

13.7

13

11.8

11

9.8

PBDT

1,922.4

1,327.2

660.3

356.3

595.4

Depreciation

136.9

131.3

122.8

104.5

86.5

Minority Interest Before NP

0

0

0

0

0

Tax

331.2

226.2

104.4

48.4

122

Deferred Tax

-23.1

-32.3

-6.4

-17.1

-2.5

Reported Profit After Tax

1,477.4

1,002

439.5

220.5

389.4

Minority Interest After NP

-1.4

0

0

0

1.5

Net Profit after Minority Interest

1,478.8

1,002

439.5

220.5

387.9

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

1,478.8

1,002

439.5

220.5

387.9

EPS (Unit Curr.)

82.56

55.78

24.08

12.09

21.39

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

150

412.5

275

225

262.5

Equity

35.8

35.8

36.5

36.5

36.4

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

60.34

45.73

37.14

27.24

35.16

PBDTM(%)

59.91

45.28

36.49

26.43

34.6

PATM(%)

46.04

34.19

24.29

16.35

22.62